购物车
全部删除
您的购物车当前为空
DHFR-IN-17 (compound j9) 是一种能够口服的SaDHFR抑制剂,其IC50值为0.97 nM。它对金黄色葡萄球菌表现出抑菌活性,最低抑菌浓度为0.031 μg/mL。
DHFR-IN-17 (compound j9) 是一种能够口服的SaDHFR抑制剂,其IC50值为0.97 nM。它对金黄色葡萄球菌表现出抑菌活性,最低抑菌浓度为0.031 μg/mL。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
DHFR-IN-17 相关产品
| 产品描述 | DHFR-IN-17 (compound j9) is an orally active SaDHFR inhibitor with an IC50 value of 0.97 nM. It exhibits antibacterial activity against Staphylococcus aureus, with a minimum inhibitory concentration of 0.031 μg/mL. |
| 体内活性 | 使用 DHFR-IN-17 (compound j9) 以 2、5、10 mg/kg 剂量连续灌胃 3 天,可显著减轻 MRSA 诱导的 C57 小鼠表皮感染的皮肤损伤。 |
| 分子式 | C17H21IN4O2 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容